Table 2.
Genotype | Sample size | Area (mm2) | Vein density mm/mm2 | Total secondary veins | Non-meeting secondary veins | Vascular islands |
---|---|---|---|---|---|---|
WT | 83 | 6.5 ± 1.5 | 1.6 ± 0.3 | 3.8 ± 0.4 | 0.7 ± 0.8 | 0 |
fkd1 | 84 | 4.6 ± 1.8a | 1.9 ± 0.4a | 3.2 ± 0.7a | 2.6 ± 0.8a | 0 |
fl1-1 | 23 | 7.3 ± 1.2a,b | 1.6 ± 0.1b | 3.8 ± 0.4b | 1.0 ± 0.8b | 0 |
fl1-2 | 15 | 5.6 ± 2.7 | 1.9 ± 0.5a | 4.0 ± 0b | 0 ± 0a,b | 0 |
fl2 | 54 | 6.6 ± 1.3b | 1.7 ± 0.3b | 3.7 ± 0.5b | 0.9 ± 0.7b | 0 |
fl3 | 45 | 6.9 ± 2.2b | 1.7 ± 0.2a,b | 3.7 ± 0.5b | 0.7 ± 0.8b | 0 |
fkd/fl1-1 | 24 | 3.4 ± 1.2a,b,c | 2.3 ± 0.4a,b,c | 2.9 ± 0.7a,c | 2.6 ± 0.8a,c | 0 |
fkd1/fl1-2 | 22 | 6.3 ± 0.9b | 1.5 ± 0.1b,c | 3.1 ± 0.8a,c | 2.1 ± 1.3a,b,c | 1.0 ± 0.0a,b,c |
fkd1/fl2 | 41 | 5.3 ± 1.4a,b,c | 2.0 ± 0.3a,c | 3.4 ± 0.6a,c | 2.4 ± 1.1a,c | 1.0 ± 0.0a,b,c |
fkd1/fl3 | 58 | 6.9 ± 1.60b | 1.6 ± 0.26b,c | 2.7 ± 0.7a,b,c | 1.9 ± 0.9a,b,c | 1.0 ± 0.0a,b,c |
fkd1/fl2/fl3 | 71 | 6.8 ± 1.9b,d* | 1.4 ± 0.3a,b,c,d | 2.4 ± 0.5a,b,c,d | 1.9 ± 0.8a,b,c,d* | 1.5 ± 0.7a,b,c,d |
fkd1/fl1-1/fl2/fl3 | 67 | 4.5 ± 1.9a,c,d,e | 1.8 ± 0.4a,c*,d,e | 2.6 ± 0.7a,b,c,d* | 2.3 ± 0.9a,b,c,d*,e | 0 |
fkd1/fl1-2/fl2/fl3 | 19 | 6.8 ± 1.1b,d* | 1.4 ± 0.1a,b,c,d | 2.7 ± 0.8a,b,c,d*,e | 2.6 ± 0.8a,c,d*,e | 1.2 ± 0.6a,b,c,d |
fl6 | 38 | 6.7 ± 1.9b | 1.8 ± 0.7a | 3.7 ± 0.6b | 1.8 ± 1.6a,b | 0 |
fl7 | 21 | 7.4 ± 1.5a,b | 1.6 ± 0.3b | 3.9 ± 0.5b | 1.0 ± 0.8b | 0 |
fkd1/fl6/fl7 | 25 | 4.6 ± 1.0a,c | 1.8 ± 0.2a,c* | 3.2 ± 0.8a,c | 2.1 ± 1.0a,b,c* | 0 |
All values are means ±SD. a is significantly different from the wild type (bold), b is significantly different from fkd1 (mutant combinations with fkd1 that are statistically different from fkd1 are underlined), c is significantly different from single mutants, d is different from double mutants, and e is different from the triple mutant. * represents a significant difference from one of the tested double mutants, but not all.